Food and Drug Administration
September 29, 2005
Slides
Vision and Overview, Jesse Goodman, MD MPH, FDA (HTM) (PPT)
FDA's Critical Path Research Initiative & Intro to the CBER Research Program, Kathryn Carbone, MD, FDA (HTM) (PPT)
Cellular Tissue and Gene Therapies Research Site Visit, Celia Witten, PhD, MD, FDA (HTM) (PPT)
Division of Cellular and Gene Therapies (DCGT), Raj Puri, MD, PhD, FDA (HTM)(PPT)
Research Management, Priorities, and Accompilshments, Suzanne Epstein, PhD, FDA (HTM) (PPT)